Evaluation of four novel genetic variants affecting hemoglobin A1c levels in a population-based type 2 diabetes cohort (the HUNT2 study)

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Hertel, Jens K ^a,b   Johansson, Stefan ^a,b   Ræder, Helge ^a,b   Platou, Carl G P ^c,d   Midthjell, Kristian ^c   Hveem, Kristian ^c   Molven, Anders ^a,b   Njølstad, Pål R ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d Levanger Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BNC2 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; GLYCOSYLATED HEMOGLOBIN; GOOSECOID PROTEIN; GSC PROTEIN, HUMAN; HEMOGLOBIN A1C PROTEIN, HUMAN; PROTEIN; SORCS1 PROTEIN, HUMAN; WDR72 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BNC2 GENE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GSC GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; POPULATION RESEARCH; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SORCS1 GENE; STATISTICAL SIGNIFICANCE; WDR72 GENE; BLOOD; GENETICS; HYPERGLYCEMIA; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GOOSECOID PROTEIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; NORWAY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTORS, CELL SURFACE;

EID: 79551581226     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-20     Document Type: Article

References (32)

1. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358(6):580-591. 10.1056/NEJMoa0706245, 18256393.
2. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993, 329(5):304-309. 10.1056/NEJM199307293290502, 8147960.
3. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998, 21(3):360-367. 10.2337/diacare.21.3.360, 9540016.
4. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009, 52(3):415-424. 10.1007/s00125-008-1246-y, 19130039.
5. Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes 2002, 51(3):833-840. 10.2337/diabetes.51.3.833, 11872688.
6. Simonis-Bik AM, Eekhoff EM, Diamant M, Boomsma DI, Heine RJ, Dekker JM, Willemsen G, van Leeuwen M, de Geus EJ. The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet 2008, 11(6):597-602. 10.1375/twin.11.6.597, 19016616.
7. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001, 50(12):2858-2863. 10.2337/diabetes.50.12.2858, 11723071.
8. An P, Freedman BI, Hanis CL, Chen YD, Weder AB, Schork NJ, Boerwinkle E, Province MA, Hsiung CA, Wu X, et al. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes 2005, 54(3):909-914. 10.2337/diabetes.54.3.909, 15734873.
9. Bonnefond A, Vaxillaire M, Labrune Y, Lecoeur C, Chevre JC, Bouatia-Naji N, Cauchi S, Balkau B, Marre M, Tichet J, et al. Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits. Diabetes 2009, 58(11):2687-2697. 10.2337/db09-0652, 2768183, 19651813.
10. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009, 41(1):89-94. 10.1038/ng.277, 19060909.
11. Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, Cavalcanti-Proenca C, Marchand M, Hartikainen AL, Sovio U, De Graeve F, et al. A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 2008, 320(5879):1085-1088. 10.1126/science.1156849, 18451265.
12. Chen WM, Erdos MR, Jackson AU, Saxena R, Sanna S, Silver KD, Timpson NJ, Hansen T, Orru M, Grazia Piras M, et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 2008, 118(7):2620-2628. 2398737, 18521185.
13. Meigs JB, Manning AK, Fox CS, Florez JC, Liu C, Cupples LA, Dupuis J. Genome-wide association with diabetes-related traits in the Framingham Heart Study. BMC Med Genet 2007, 8(Suppl 1):S16. 10.1186/1471-2350-8-S1-S16, 1995610, 17903298.
14. Pare G, Chasman DI, Parker AN, Nathan DM, Miletich JP, Zee RY, Ridker PM. Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study. PLoS Genet 2008, 4(12):e1000312. 10.1371/journal.pgen.1000312, 2596965, 19096518.
15. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009, 41(1):77-81. 10.1038/ng.290, 2682768, 19060907.
16. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, Brodsky J, Jones CG, Zaitlen NA, Varilo T, Kaakinen M, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009, 41(1):35-46. 10.1038/ng.271, 2687077, 19060910.
17. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010, 42(2):105-116. 10.1038/ng.520, 3018764, 20081858.
18. Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, Tewhey R, Rieder MJ, Hall J, Abecasis G, et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 2008, 57(11):3112-3121. 10.2337/db08-0516, 2570409, 18678614.
19. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, Bouatia-Naji N, Langenberg C, Prokopenko I, Stolerman E, et al. Common variants at ten genomic loci influence hemoglobin A1C levels via glycemic and non-glycemic pathways. Diabetes 2010, 59(12):3229-3239. 10.2337/db10-0502, 20858683.
20. Paterson AD, Waggott D, Boright AP, Hosseini SM, Shen E, Sylvestre MP, Wong I, Bharaj B, Cleary PA, Lachin JM, et al. A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes 2010, 59(2):539-549. 10.2337/db09-0653, 2809960, 19875614.
21. Florez JC. A Genome-Wide Association Study of Treated A1C - A Genetic Needle in an Environmental Haystack?. Diabetes 2010, 59(2):332-334. 10.2337/db09-1636, 2809959, 20103712.
22. Johansson S, Raeder H, Eide SA, Midthjell K, Hveem K, Sovik O, Molven A, Njolstad PR. Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians. Diabetes 2007, 56(12):3112-3117. 10.2337/db07-0513, 17827402.
23. Hertel JK, Johansson S, Raeder H, Midthjell K, Lyssenko V, Groop L, Molven A, Njolstad PR. Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia 2008, 51(6):971-977. 10.1007/s00125-008-0982-3, 18437351.
24. Eide SA, Raeder H, Johansson S, Midthjell K, Sovik O, Njolstad PR, Molven A. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med 2008, 25(7):775-781. 10.1111/j.1464-5491.2008.02459.x, 18513305.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575. 10.1086/519795, 1950838, 17701901.
26. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19(1):149-150. 10.1093/bioinformatics/19.1.149, 12499305.
27. Clee SM, Yandell BS, Schueler KM, Rabaglia ME, Richards OC, Raines SM, Kabara EA, Klass DM, Mui ET, Stapleton DS, et al. Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet 2006, 38(6):688-693. 10.1038/ng1796, 16682971.
28. Granhall C, Park HB, Fakhrai-Rad H, Luthman H. High-resolution quantitative trait locus analysis reveals multiple diabetes susceptibility loci mapped to intervals < 800 kb in the species-conserved Niddm1i of the GK rat. Genetics 2006, 174(3):1565-1572. 10.1534/genetics.106.062208, 1667097, 16951059.
29. Florez JC, Manning AK, Dupuis J, McAteer J, Irenze K, Gianniny L, Mirel DB, Fox CS, Cupples LA, Meigs JB. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 2007, 56(12):3063-3074. 10.2337/db07-0451, 17848626.
30. Goodarzi MO, Lehman DM, Taylor KD, Guo X, Cui J, Quinones MJ, Clee SM, Yandell BS, Blangero J, Hsueh WA, et al. SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes 2007, 56(7):1922-1929. 10.2337/db06-1677, 17426289.
31. Holmen J, Midthjell K, Krüger T, Langhammer A, Holmen T, Bratberg G, Vatten L, Lund-Larsen P. The Nord-Trøndelag Health Study 1995-97 (HUNT2): Objectives, contents, methods and participation. Norw J Epidemiol 2003, 13:19-32.
32. Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study. Scand J Clin Lab Invest 2009, 69(2):282-287. 10.1080/00365510802538188, 18972257.